Stay updated on BOOST3 Clinical Trial
Sign up to get notified when there's something new on the BOOST3 Clinical Trial page.

Latest updates to the BOOST3 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check30 days agoNo Change Detected
- Check38 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.9%
- Check45 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check59 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has added numerous new contacts, including several medical professionals, and updated the version from v2.13.3 to v2.14.0.SummaryDifference5%
- Check96 days agoChange DetectedThe Brain Oxygen Optimization in Severe TBI (BOOST3) study has expanded from 45 to 48 locations and updated its protocol, now allowing for a lower PaO2/FiO2 ratio threshold from <200 to <150.SummaryDifference6%
Stay in the know with updates to BOOST3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BOOST3 Clinical Trial page.